Anesthesia market set to grow to $4.3B as population and use expands

New products, a growing world population expected to reach 6.8 billion in three years, as well as the aging of that population, will push anesthesia drug sales up 1.9% to nearly $4.3 billion by 2011, according to Anesthesia Drugs: Worldwide Markets, a new report by analysts at Kalorama Information.

More than 300 million surgical procedures required anesthetic administration worldwide in 2006, and Kalorama expects that the number will rise accordingly as the incidence and prevalence of disease grows with the expanding global population.

Adjunctive therapies, drugs given in the perioperative period to facilitate and/or augment the anesthetic process, will likely represent the largest percentage of the growth during the forecast period, primarily due to new developments in the anesthesia reversal market. The adjunctive therapies sector grew from $793.3 million in 2004 to $825.5 million in 2006 and is expected to reach $1.2 billion by 2011, an increase of 8.2%.